Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Quarterly results
Director departure
Appointed director
|
|
WaferGen Bio-systems, Inc. (WGBS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/01/2017 |
8-K
| Quarterly results |
| 02/15/2017 |
8-K
| Form 8-K - Current report |
| 11/28/2016 |
8-K
| Form 8-K - Current report |
| 11/15/2016 |
8-K
| Form 8-K - Current report |
| 11/08/2016 |
8-K
| Quarterly results |
| 10/31/2016 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 10/28/2016 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 10/27/2016 |
8-K
| Form 8-K - Current report |
| 08/09/2016 |
8-K
| Quarterly results |
| 05/26/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/13/2016 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...|
Docs:
|
"Agreement and Plan of Merger, among Takara Bio USA Holdings, Inc., Walrus Acquisition Corporation, WaferGen Bio-systems, Inc. and Takara Bio USA, Inc",
"Deposit Agreement, between Takara Bio USA Holdings, Inc. and WaferGen Bio-systems, Inc",
"Second Amendment to Executive Employment Agreement, effective as of May 12, 2016, between WaferGen Bio-systems, Inc. and Ivan Trifunovich",
"WaferGen Bio-systems and Takara Bio Inc. Announce Merger Agreement Transaction scheduled to close following completion of the 2016 fiscal year" |
|
| 05/10/2016 |
8-K
| Form 8-K - Current report |
| 03/09/2016 |
8-K
| Form 8-K - Current report |
| 03/08/2016 |
8-K
| Form 8-K - Current report |
| 02/16/2016 |
8-K
| Termination of a Material Definitive Agreement |
| 01/28/2016 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 12/28/2015 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 11/10/2015 |
8-K
| Quarterly results |
| 10/21/2015 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
| 08/05/2015 |
8-K
| Quarterly results |
| 07/07/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/10/2015 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/11/2015 |
8-K
| Appointed a new director|
Docs:
|
"Carlson Employment Agreement, effective as of May 11, 2015, between the Company and Rolland Carlson",
"Amendment to Executive Employment Agreement, effective as of May 11, 2015, between the Company and Ivan Trifunovich",
"WaferGen Bio-systems Appoints Life Sciences Industry Veteran, Rolland D. Carlson, Ph.D., President & CEO Ivan Trifunovich, Ph.D., Appointed Executive Chairman of the Board New CEO to Lead WaferGen’s Commercial Efforts in Single Cell Analysis" |
|
| 05/11/2015 |
8-K
| Quarterly results |
| 03/16/2015 |
8-K
| Quarterly results |
| 11/18/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/07/2014 |
8-K
| Quarterly results |
| 08/18/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/11/2014 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 08/07/2014 |
8-K
| Quarterly results |
| 07/18/2014 |
8-K
| Resignation/termination of a director|
Docs:
|
"WaferGen Bio-Systems Announces Appointment of Ivan Trifunovich as Chairman of the Board; Joel Kanter to Serve as Lead Independent Director FREMONT, Calif., July 18, 2014 /PRNewswire/ -- WaferGen Bio-systems, Inc. today announced that its Board of Directors has appointed Ivan Trifunovich, the company’s President and Chief Executive Officer, as Chairman of the Board. Joel Kanter, a director of the company since 2007, will serve as lead independent director. Alnoor Shivji, the company’s Chairman since 2002, resigned from the board to focus full time on a new startup venture. “I would like to thank Alnoor for his service to WaferGen while it grew from a start-up to a public company with commercially viable products. Speaking for the whole Board, I wish him success in his future endeavors”, com..." |
|
| 06/30/2014 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits|
Docs:
|
"Certificate of Amendment to the Amended and Restated Articles of Incorporation of the Company",
"WaferGen Bio-systems Announces Reverse Stock Split as it Pursues NASDAQ Listing FREMONT, Calif., June 30, 2014 /PRNewswire/ -- WaferGen Bio-systems, Inc. announced today a 1-for-10 reverse stock split of its outstanding common stock. The company completed the reverse stock split as it seeks to list its common stock on the NASDAQ Capital Market. The reverse stock split became effective at 1:01 p.m. Pacific Time on June 30, 2014. WaferGen’s common stock will begin trading on a split adjusted basis on the OTCBB when the market opens on July 1, 2014. The common stock will have a new CUSIP number, 93041P 308, and will trade for 20 days under the temporary trading symbol, “WGBSD,” with the “D” added to signify that the reverse stock split has occurred. As a result of the reverse stock split, eve..." |
|
| 05/30/2014 |
8-K
| Appointed a new director |
| 05/13/2014 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
|
|
|